Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208.2 SEK | +0.10% | +81.83% | +63.81% |
May. 31 | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
May. 31 | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
Sales 2024 * | 1.88B 179M | Sales 2025 * | 3.2B 304M | Capitalization | 11.17B 1.06B |
---|---|---|---|---|---|
Net income 2024 * | -38M -3.61M | Net income 2025 * | 1.12B 107M | EV / Sales 2024 * | 5.88 x |
Net cash position 2024 * | 125M 11.9M | Net cash position 2025 * | 1.21B 115M | EV / Sales 2025 * | 3.11 x |
P/E ratio 2024 * |
37.4
x | P/E ratio 2025 * |
9.03
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.29% |
Latest transcript on Calliditas Therapeutics AB
1 day | +0.10% | ||
1 week | +81.83% | ||
1 month | +89.27% | ||
3 months | +89.10% | ||
6 months | +122.79% | ||
Current year | +63.81% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 17-05-17 | |
Director of Finance/CFO | 47 | 17-07-31 | |
Chief Tech/Sci/R&D Officer | 60 | 20-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 23-05-29 |
Henrik Stenqvist
BRD | Director/Board Member | 57 | 21-12-31 |
Elmar Schnee
CHM | Chairman | 65 | 19-05-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 1 M€ | -.--% | - | |
0.00% | 29 M€ | -2.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 208.2 | +0.10% | 1,382,491 |
24-05-30 | 208 | +2.36% | 3,701,262 |
24-05-29 | 203.2 | +0.40% | 1,893,924 |
24-05-28 | 202.4 | +78.17% | 7,863,576 |
24-05-27 | 113.6 | -0.79% | 244,141 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.81% | 1.06B | |
+15.54% | 78.51B | |
+12.05% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
+21.94% | 2.48B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B |
- Stock Market
- Equities
- CALTX Stock